Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles

Atherosclerosis

Volumn 208, Issue 1, 2010, Pages 177-182

  Norata, Giuseppe Danilo ^a,b   Garlaschelli, Katia ^b   Grigore, Liliana ^b   Raselli, Sara ^b   Tramontana, Simona ^b   Meneghetti, Fiorella ^a   Artali, Roberto ^a   Noto, Davide ^c   Cefalù, Angelo Baldassare ^c   Buccianti, Gherardo ^d   Averna, Maurizio ^c   Catapano, Alberico Luigi ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale Bassini   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d The Italian Society for the Prevention of Kidney Disease   (Italy)

Author keywords

IMT; In silico modeling; Molecular genetics; PCSK9

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROPROTEIN CONVERTASE SUBTILISIN LIKE KEXIN TYPE 9 PROTEIN; UNCLASSIFIED DRUG; VALINE;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; COMPUTER MODEL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ALLELES; APOLIPOPROTEINS E; CAROTID ARTERY, COMMON; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SERINE ENDOPEPTIDASES; TUNICA INTIMA; TUNICA MEDIA;

EID: 73449143804     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.023     Document Type: Article

References (21)

1. Park S.W., Moon Y.A., and Horton J.D. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J Biol Chem 279 48 (2004) 50630-50638
2. Benjannet S., Rhainds D., Essalmani R., et al. NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem 279 47 (2004) 48865-48875
3. Peterson A.S., Fong L.G., and Young S.G. PCSK9 function and physiology. J Lipid Res 49 6 (2008) 1152-1156
4. Horton J.D., Cohen J.C., and Hobbs H.H. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50 Suppl (2009) S172-S177
5. Abifadel M., Varret M., Rabes J.P., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34 2 (2003) 154-156
6. Kotowski I.K., Pertsemlidis A., Luke A., et al. A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet 78 3 (2006) 410-422
7. Chen S.N., Ballantyne C.M., Gotto Jr. A.M., Tan Y., Willerson J.T., and Marian A.J. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 45 10 (2005) 1611-1619
8. Evans D., and Beil F.U. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women. BMC Med Genet 7 (2006) 66
9. Scartezini M., Hubbart C., Whittall R.A., Cooper J.A., Neil A.H., and Humphries S.E. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men. Clin Sci (Lond) 113 11 (2007) 435-441
10. Polisecki E., Peter I., Robertson M., et al. Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. Atherosclerosis 200 1 (2008) 95-101
11. Abboud S., Karhunen P.J., Lutjohann D., et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS ONE 2 10 (2007) e1043
12. Norata G.D., Garlaschelli K., Ongari M., et al. Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med 258 1 (2005) 21-27
13. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., and Catapano A.L. Effects of fractalkine receptor variants on common carotid artery intima-media thickness. Stroke 37 6 (2006) 1558-1561
14. Norata G.D., Ongari M., Garlaschelli K., Raselli S., Grigore L., and Catapano A.L. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156 2 (2007) 279-284
15. Paternoster L., Martinez Gonzalez N.A., Lewis S., and Sudlow C. Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke 39 1 (2008) 48-54
16. Noto D., Barbagallo C.M., Cavera G., et al. Leukocyte count, diabetes mellitus and age are strong predictors of stroke in a rural population in southern Italy: an 8-year follow-up. Atherosclerosis 157 1 (2001) 225-231
17. Barbagallo C.M., Cavera G., Sapienza M., et al. Nutritional characteristics of a rural Southern Italy population: the Ventimiglia di Sicilia Project. J Am Coll Nutr 21 6 (2002) 523-529
18. Phillips J.C., Braun R., Wang W., et al. Scalable molecular dynamics with NAMD. J Comput Chem 26 16 (2005) 1781-1802
19. Pettersen E.F., Goddard T.D., Huang C.C., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25 13 (2004) 1605-1612
20. Kwon H.J., Lagace T.A., McNutt M.C., Horton J.D., and Deisenhofer J. Molecular basis for LDL receptor recognition by PCSK9. Proc Natl Acad Sci USA 105 6 (2008) 1820-1825
21. Cameron J., Holla O.L., Berge K.E., et al. Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion. FEBS J 275 16 (2008) 4121-4133